HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Clinical trial NCT06770452 · RECRUITING

Trial details

NCT number: NCT06770452
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Carcinoma

Start date: 2025-03-25
Primary completion: 2027-02-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.